Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

    NEXT STORY
    The 2019 U.S. HIV Market: Analyses & Forecasts Through 2014-2024
    PREV STORY
    AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Union leaders representing more than 200,000 nurses, health professionals and care workers demand public consultation on Ford government’s omnibus health care bill

    author_avatar
    NASDAQ Market News

    R1 RCM Reports Fourth Quarter and Full Year 2018 Results

    author_avatar
    NASDAQ Market News

    Helsinn Provides Grant for ESMO’s Preceptorship Programme for Supportive and Palliative Care

    author_avatar
    NASDAQ Market News